Amarin Corporation plc   

(NASDAQ ticker: AMRN)| www.amarincorp.com | is a biopharmaceutical company focused on improving the treatment of cardiovascular disease.

 

 

Auspex Pharmaceuticals, Inc. www.auspexpharma.com | is a developer of next-generation medicines with improved safety and performance and a pioneer in the targeted application of deuterium chemistry to clinically validated drugs. 

 

Clarus Therapeutics, Inc.www.clarustherapeutics.com | is developing new approaches for hormone replacement therapy.



NeuroTherapeutics Pharma, Inc.

| www.ntprx.com | is focused on the development of novel therapeutics for the treatment of CNS disorders.

 

 

Ocera Therapeutics, Inc.  | www.oceratherapeutics.com  | is focused on the development of pharmaceutical products for gastrointestinal and liver diseases.

 

 

Oriel Therapeutics, Inc.  | www.orieltherapeutics.com | is a respiratory drug delivery company developing dry powder delivery systems for the treatment of asthma and COPD.

 

 

Quinnova Pharmaceuticals, Inc.  |  www.quinnova.com  | is a specialty pharmaceutical company focused on the development and commercialization of prescription drug products based on innovative drug delivery platforms for the dermatology market. 

 

 

Solstice Neurosciences, Inc. | www.solsticeneuro.com |

manufactures and markets Myobloc™, an FDA approved formulation of Botulinum Toxin type B, for the treatment of neurologically-induced muscle spasms.

 

 

Zogenix, Inc.  | www.zogenix.com | is a specialty pharmaceutical company focused on the development and commercialization of medicines to treat CNS disorders and pain, with an initial focus on SUMAVEL™ DosePro™, a needle-free migraine treatment.


« back to top

    © 2010 Thomas, McNerney & Partners - All Rights Reserved.
|